Oticon vs ReSound Hearing Aids 2026: Dual AI vs AcoustIQ AI

Quick Answer: For most buyers cross-shopping premium prescription hearing aids, Oticon wins on a natural, open soundscape — its current flagship, Reveal (launched August 2026), runs a Dual AI system that splits speech and ambient sound into two separate processing paths instead of clamping down on everything but one speaker. ReSound’s Sensia (also launched August 2026) counters with a new AcoustIQ AI classifier and 4-microphone beamforming built specifically to isolate and follow one voice in noise. Both are prescription-only, fitted by an audiologist; Oticon Reveal pricing is still being finalized by providers (predecessor Intent ran $2,898-$4,598/pair), while ReSound Sensia runs $2,798-$3,798/pair — both in line with the ~$3,000 average reported by the President’s Council of Advisors on Science and Technology (PCAST).

Updated October 3, 2026 — both brands replaced their flagships in August 2026. We previously listed the Oticon Intent (4D Sensor) and ReSound Nexia (2023) as the current flagships. Oticon has since released Reveal (Dual AI speech/context processing), and ReSound has released two newer platforms, the Vivia (2025) and current flagship Sensia (AcoustIQ AI classifier + 4-mic beamforming). The Nexia remains available as ReSound’s lower-priced value all-rounder. Pricing and product details below have been updated to match — see our full Oticon Intent review and ReSound Nexia review for the outgoing flagships’ current standing.

Oticon and ReSound are two of the “big five” global hearing-aid makers, and both trace back to Danish hearing-care heritage — Oticon through parent company Demant (roots to 1904), ReSound through parent company GN (roots to 1869). Where they split is philosophy and connectivity strategy, and only one of them also sells a cheaper OTC sibling from the same parent company. Here’s how the two flagships and supporting lineups actually compare.

Oticon vs ReSound at a glance, by the numbers

• Dual AI vs AcoustIQ AI classifier — Oticon’s Reveal (August 2026) runs two AI systems at once, one dedicated to speech and one to everything else in the room; ReSound’s Sensia (also August 2026) runs a single AcoustIQ AI classifier paired with 4-microphone beamforming to isolate and follow one voice.
• Both brands replaced their flagships in the same month — Oticon’s Intent gave way to Reveal and ReSound’s Nexia (already once succeeded by the Vivia in 2025) gave way to Sensia, both in August 2026, two generations removed from the Nexia that first brought Bluetooth LE Audio and Auracast to the brand.
• 1904 vs 1869 — Oticon’s parent Demant traces its hearing-care roots to 1904; ReSound’s parent GN traces its roots to 1869, making GN the older of the two hearing-care lineages even though ReSound as a brand name dates to 1943.
• $2,898-$4,598 vs $2,798-$3,798 — Oticon’s outgoing Intent typically ran $2,898-$4,598 a pair and is the closest pricing anchor while providers finalize Reveal’s own pricing; ReSound’s current flagship Sensia runs $2,798-$3,798 a pair, both near the roughly $3,000 PCAST average for a prescription pair.
• 28.8 million U.S. adults could benefit from a hearing aid per the NIDCD (National Institute on Deafness and Other Communication Disorders), yet fewer than one in three adults over 70 who could benefit has ever used one — the underserved market both premium brands compete for.

Oticon vs ReSound: head-to-head

The case for Oticon

Once you’re fitted with a prescription pair, wax filters and domes become a recurring purchase, not a one-time one — try Amazon Prime free for 30 days so reorders land in two days instead of a week. Oticon’s biggest practical edge over ReSound is a natural, low-fatigue soundscape: the Dual AI split between speech and ambient sound (and the BrainHearing approach behind it) is well regarded by audiologists for sounding less processed than brands that clamp down harder on background noise. See our full Oticon Intent review for background on the outgoing flagship’s tiered pricing, or our Oticon hearing aids review for the complete lineup.

The case for ReSound

ReSound’s biggest practical edge over Oticon is its newest AI plus a built-in cheaper exit ramp: the Sensia’s AcoustIQ classifier and 4-mic beamforming target noise isolation more directly than Oticon’s dual-track approach, and — unlike Oticon — ReSound offers a same-parent OTC sibling (Jabra Enhance Select) if you ever want to switch to a self-fitting device without leaving the GN sound platform. If budget matters more than the newest AI, the earlier Nexia remains available at a lower ~$2,298-$2,998/pair — see our full ReSound Nexia review for that generational tradeoff, or our ReSound hearing aids review for the complete lineup.

Which should you buy?

• Choose Oticon if you want Reveal’s Dual AI speech/context split and a more natural, low-fatigue soundscape, you value the BrainHearing philosophy, or discretion matters most and you’d consider the custom Oticon Own.
• Choose ReSound if you want Sensia’s newest AcoustIQ AI noise isolation, future-proof Bluetooth LE Audio and Auracast public broadcast audio matter to you, you want the most natural sound localization via M&RIE, or you’d like the option to switch to a same-parent OTC device later — Jabra Enhance Select — without changing sound platforms.
• Choose neither, for now, if your hearing loss is perceived mild-to-moderate and budget matters more than premium AI or connectivity features — a self-fitting OTC pair like the Jabra Enhance Select covers most everyday needs for a fraction of the price, and our best OTC hearing aids ranking covers the rest of that market.

Both brands appear alongside the rest of the field in our best hearing aid brands roundup and our overall best hearing aids ranking. If you’re weighing ReSound against a rival with a dedicated AI noise chip instead, see our ReSound vs Phonak comparison; for Oticon against another Danish-engineered rival, see our Widex vs Oticon comparison.

When to see a professional instead of comparison-shopping

Oticon and ReSound are both prescription devices, so a licensed audiologist is already part of the process — but get evaluated promptly, rather than shopping by spec sheet, if any of these apply:

• Your hearing loss is severe, came on suddenly, or affects one ear only — see our severe hearing loss guide as background, then book a medical evaluation.
• You have ear pain, drainage, or a history of ear infections.
• Your tinnitus is pulsing or one-sided — read our tinnitus guide and see a doctor first.
• You’re fitting a child — both Oticon and ReSound make devices that can suit pediatric loss, which needs a pediatric audiologist, not a general comparison article.

The bottom line

There’s no wrong choice between Oticon and ReSound — both are top-five global brands from Danish hearing-care lineages with genuinely different strengths, and both replaced their flagships in August 2026. Oticon’s Reveal wins on a natural, open soundscape via its Dual AI speech/context split and the BrainHearing philosophy; ReSound’s Sensia wins on the newest AI-powered noise isolation via its AcoustIQ classifier and 4-mic beamforming. Expect Reveal pricing to land near predecessor Intent’s $2,898-$4,598/pair once providers finalize it, while Sensia runs $2,798-$3,798/pair — both near the $3,000 PCAST average, with value-tier options (More, Nexia) landing lower still. The clearest tiebreaker: ReSound’s parent GN also makes the OTC Jabra Enhance Select if you might want a same-platform self-fitting option later — Oticon’s parent Demant sells no OTC line of its own. Otherwise, ask your audiologist to demo both — or browse Oticon and ReSound accessories on Amazon while you decide.